Quality Online Education Group Inc. - Quarter Report: 2009 March (Form 10-Q)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
FORM 10-Q
[X ] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2009 or
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from______to________
LIFE NUTRITION PRODUCTS, INC.
(Exact name of registrant as specified in its charter)
Commission File Number: 333-152432
Delaware 42-1743717
(State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.)
Michael M. Salerno
Chief Executive Officer
121 Monmouth Street, Suite A
Red Bank, New Jersey 07701
(732)758-1577
(Address of principal executive offices)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. (X)Yes ()No
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). ( ) Yes () No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.
See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act.
Large accelerated filer () Accelerated filer () Non-accelerated filer () Smaller reporting company (X)
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). (X) Yes () No
As of March 31, 2009 there were 14,055,000 shares of common stock outstanding with a par value of $0.0001.
Table of Contents | ||
Page: | ||
Part I. | FINANCIAL INFORMATION | |
Item 1. Condensed Financial Statements | 3 | |
Condensed Balance Sheets as of March 31, 2009 and December 31, 2008 (unaudited) | 3 | |
Condensed Statements of Operations for the Three Months Ended March 31, 2009 and 2008 (unaudited) | 4 | |
Condensed Statements of Cash Flows for the Three Months Ended March 31, 2009 and 2008 (unaudited) | 5 | |
Condensed Notes to Financial Statements (unaudited) | 6-9 | |
Item 2. Managements Discussion and Analysis of Financial Condition | 10-13 | |
and Results of Operations | ||
Item 3. Quantitative and Qualitative Disclosures about Market Risk | 13-15 | |
Item 4. Controls and Procedures | 15 | |
Part II. | OTHER INFORMATION | |
Item 1. Legal Proceedings | 16 | |
Item 1A. Risk Factors | 16 | |
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds | 16 | |
Item 3. Defaults Upon Senior Securities | 16 | |
Item 4. Submissions of Matters to a Vote of Security Holders | 16 | |
Item 5. Other Information | 16 | |
Unregistered Sales of Equity Securities | ||
Item 6. Exhibits | 17 | |
Signatures | 17 |
Part I. FINANCIAL INFORMATION | |||||
Item 1. Financial Statements | |||||
Life Nutrition Products, Inc. | |||||
Condensed Balance Sheets (unaudited) | |||||
As of March 31, 2009 and December 31, 2008 | |||||
March 31, | December 31, | ||||
Assets | 2009 | 2008 | |||
Current Assets | |||||
Inventory | $ | 307 | $ | 307 | |
Total Current Assets | 307 | 307 | |||
Equipment, net | 2,564 | 2,708 | |||
Total Assets | $ | 2,871 | $ | 3,015 | |
Liabilities and Stockholders (Deficit) | |||||
Liabilities | |||||
Account payable and accrued expenses | $ | 11,288 | $ | 49 | |
Liability for stock to be issued | 23,015 | 20,000 | |||
Total Liabilities | 34,303 | 20,049 | |||
Stockholders (Deficit) | |||||
Preferred stock, $0.0001 par value, 2,000,000 authorized, | |||||
none issued and outstanding | - | - | |||
Common stock $0.0001 par value, 50,000,000 authorized, | 1,406 | 1,406 | |||
14,055,000 issued and outstanding as of March 31, 2009 and | |||||
14,055,000 issued and outstanding as of December 31, 2008 | |||||
Additional paid-in capital | 439,070 | 439,070 | |||
Accumulated deficit | (471,908) | (457,510) | |||
Total Stockholders (Deficit) | (31,432) | (17,034) | |||
Total Liabilities and Stockholders (Deficit) | $ | 2,871 | $ | 3,015 | |
The accompanying footnotes are an integral part of these condensed financial statements. |
3
Life Nutrition Products, Inc | ||||
Condensed Statements of Operations (unaudited) | ||||
For the Three Months Ended | ||||
2009 | 2008 | |||
Revenue | $ | 959 | $ | 360 |
Cost of Revenues | - | - | ||
Gross Profit | 959 | 360 | ||
Expenses | ||||
Selling General and Administrative | 15,357 | 23,246 | ||
Other Income (Expense) | ||||
Interest Income | - | 9 | ||
Interest Expense | - | (1,137) | ||
Total Expenses | 15,357 | 24,374 | ||
Loss Before Provision For Income Taxes | (14,398) | (24,014) | ||
Provision For Income Taxes | - | - | ||
Net Loss attributable to common shareholders | $ | (14,398) | $ | (24,014) |
Weighted Average Shares of Common Stock Outstanding-Basic and Diluted | 14,055,000 | 10,000,000 | ||
Net Loss per Basic and Diluted Common Share | $ | - | $ | - |
The accompanying footnotes are an integral part of these condensed financial statements.
4
Life Nutrition Products, Inc. | |||||
Condensed Statements of Cash Flows (unaudited) | |||||
For the Three Months Ended March 31, | |||||
2009 | 2008 | ||||
Cash Flows from Operating Activities | |||||
Net Loss | $ | (14,398) | $ | (24,014) | |
Depreciation | 144 | - | |||
Stock Based Compensation | 3.015 | - | |||
Increase in Accounts Payable and Accrued Expenses | 11,239 | 227 | |||
Net cash used in operating activities | - | (23,787) | |||
Cash Flows from Financing Activities | |||||
Repayment of Line of Credit | - | (73,208) | |||
Repayment of Officer Loan | - | (74,345) | |||
Proceeds from Stock Issuance | - | 210,000 | |||
Net cash provided by financing activities | - | 62,447 | |||
Net increase in cash | - | 38,660 | |||
Cash at beginning of period | - | 856 | |||
Cash at end of period | $ | - | $ | 39,516 | |
SUPPLEMENTARY DISCLOSURES OF CASH FLOW INFORMATION | |||||
Cash paid during the period for: | |||||
Interest | $ | - | $ | 1,137 | |
Income taxes | $ | - | $ | - | |
The accompanying footnotes are an integral part of these condensed financial statements. |
5
Life Nutrition Products, Inc.
Condensed Notes to the Financial Statements (unaudited)
March 31, 2009 and 2008
1. NATURE OF OPERATIONS AND BASIS OF PRESENTATION
The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States for the interim financial information and with the instructions to Form 10-Q and Regulation S-K as promulgated by the Securities and Exchange Commission. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. In the opinion of management, all normal recurring adjustments considered necessary for a fair statement of the results of operations have been included. The results of operations for the three months ended March 31, 2009 are not necessarily indicative of the results of operations for the full year. When reading the financial information contained in this Quarterly Report, reference should be made to the financial statements, schedule, and notes contained in the Companys annual report for the year ended, December 31, 2008.
Life Nutrition Products, Inc was originally organized as a New Jersey limited liability company in February 2005 under the name Life Nutrition Products, LLC ("LNP"). On September 24, 2007, Life Nutrition Products, Inc. a Delaware Corporation was formed and merged with LNP. Under the terms of the merger10 million shares of common stock were issued to the LNP Members to acquire all of LNP's membership interests. After the merger, 10 million shares of common stock were outstanding, all of which were owned by LNP's two founders, Michael M. Salerno, President and Richard G. Birn, Vice President.
Our primary business purpose is to market over-the-counter, all-natural dietary supplements under the trade names: Trim For Life3 Appetite Control and Trim For Life3 Energy Formula. The Trim For Life3 Appetite Control Formula is patent pending and supported by scientific studies. The Trim For Life3 Energy Formula is a proprietary formula blend.
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Use of Estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (GAAP) requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from these estimates.
Cash and Cash Equivalents
Highly liquid investments with maturities of three months or less at the date of purchase (that are readily convertible to cash) are considered to be cash equivalents and are stated at cost, which approximates market value.
Accounts Receivable
The Company does not extend credit to customers.
Inventory
Inventory is stated at the lower of cost or market. Cost is determined using the first-in first-out method. Inventories consist of only finished goods.
Property and Equipment
Property and equipment are stated at cost. Depreciation and amortization are computed on the straight-line method based on the estimated useful lives of the assets.
6
Life Nutrition Products, Inc.
Condensed Notes to the Financial Statements (unaudited)
(Continued)
March 31, 2009 and 2008
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
Revenue Recognition
The Company's sales are placed over the Internet or by phone and payment is taken by either credit card or check. Product is shipped immediately upon receipt of order. Revenue is recognized at the time of shipment. Life Nutrition Products offers customers the right to return certain of its products. Revenue for these products is recognized in accordance with Statement of Financial Accounting Standards (SFAS) No. 48, Revenue Recognition When Right of Return Exists. Among its criteria for revenue recognition from sales transactions where a buyer has a right of return, SFAS No. 48 requires the amount of future returns to be reasonably estimated. We were unable to reasonably estimate returns for the periods reported, therefore, the recognition of revenue was recognized at the time of shipment.
Net (Loss) Per Share of Common Stock
The following table sets forth the computation of basic and diluted earnings per share:
Period Ended | |||
March 31, | March 31, | ||
2009 | 2008 | ||
Net Loss | (14,398) | (24,014) | |
Weighted Average common stock shares outstanding (basic) | 14,055,000 | 10,000,000 | |
Options | - | - | |
Warrants | - | - | |
Weighted Average common stock shares outstanding (diluted) | 14,055,000 | 10,000,000 |
All dilutive securities were not included in the calculation of dilutive earnings per share because the effect would be anti-dilutive when the Company has incurred a loss from operations. There are no dilutive securities, such as warrants or options, outstanding.
Recent Accounting Pronouncements
As noted in our annual report on Form 10-K for the year ended December 31, 2008 filed in April 2009, recent accounting pronouncements issued by the Financial Accounting Standards Board are not believed by the Company to have a significant material impact on the financial statements.
7
Life Nutrition Products, Inc.
Condensed Notes to the Financial Statements (unaudited)
(Continued)
March 31, 2009 and 2008
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
Shipping and Handling
Shipping and handling costs have been expensed as incurred and have been included in operating expenses. Shipping and handling expense was $107 and $45 for the three month period ended March 31, 2009 and 2008, respectively.
Advertising
Advertising costs have been expensed as incurred and have been included in operating expenses. Advertising expense was $525 and $0 for the three month period ended March 31, 2009 and 2008, respectively.
3. PROPERTY AND EQUIPMENT
At March 31, 2009 and December 31, 2008, property and equipment consists of the following:
March 31, | December 31, | |||
2009 | 2008 | Estimated | ||
Useful Lives | ||||
Computer Equipment | $4,324 | $1,324 | 3 years | |
Website Development | 4,315 | 4,315 | 3 years | |
Less: accumulated depreciation and amortization | (6,075) | (5,198) | ||
$2,564 | $2,708 | |||
4. LINE OF CREDIT | ||||
Wachovia |
On October 25, 2006 the Company closed on a business line of credit with Wachovia Bank in the amount of $50,000. The principal bears interest at the prime rate plus 2.5% . The Company utilized the $50,000 line of credit for the year ending December 31, 2007. For the year ended, December 31, 2008 there was $0 drawn on the line and $50,000 available. For the three months ending March 31, 2009 there was $0 drawn on the available line of credit of $50,000.
Washington Mutual
On October 18, 2006 the Company closed on a business line of credit with Washington Mutual Bank in the amount of $25,000. The principal bears interest at the prime rate plus 3%. The Company utilized the $25,000 line of credit for the year ending December 31, 2007. For the year ended, December 31, 2008 there was $0 drawn on the line and $25,000 available. For the three months ending March 31, 2009 there was $0 drawn on the available line of credit of $25,000.
8
Life Nutrition Products, Inc.
Condensed Notes to the Financial Statements (unaudited)
(Continued)
March 31, 2009 and 2008
5. PRIVATE PLACEMENT
Private placement
On December 3, 2007 the Company offered for sale to accredited investors up to fifty units at a purchase price per unit of $10,000. Each unit consists of 150,000 shares of common stock, $0.0001 par value per share. The minimum offering amount is 20 units ($200,000) and the maximum offering is 50 Units ($500,000). The offering remained open until November 1, 2008. For the year ended, December 31, 2008, a total of 25 units were sold and $250,000 of capital was raised. For the three months ending March 31, 2009 no units were sold.
6. STOCK BASED COMPENSATION
The Company follows the provisions of EITF 96-18, Accounting for Equity Instruments That Are Issued to Other Than Employees for Acquiring, or in Conjunction with Selling, Goods or Services, which requires that stock grants to non-employees be measured at the fair value of the equity instruments issued or the consideration received, whichever is more reliably measurable. In the first quarter 2009, we issued a total of 45,000 shares of common stock for various administrative services rendered. We recorded compensation expense in the amount $3,015 based on the value of stock ($0.067) as determined in our recent private placement.
7. RELATED PARTIES
The Company from time to time receives financial advances for certain relations and related transactions such as payroll for the three months ended March 31, 2009 and 2008, respectively. The recorded amounts were $3,015 and $0 for the three months ended March 31, 2009 and 2008, respectively. The Company leases office space on a month to month basis in the amount of $500 from 121 Monmouth Street, LLC, a limited liability company owned, in part, by our CEO Michael M. Salerno.
8. GOING CONCERN
The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplates continuation of the Company as a going concern.
The Company has suffered recurring losses and experiences a deficiency of cash flow from operations. These matters raise substantial doubt about the Company's ability to continue as a going concern. The continued operations of the Company are dependent upon the Company's ability to raise capital and/or generate positive cash flows from operations.
Management may achieve profitability and generate positive cash flows through possible acquisition or merger. However, there is no guarantee that a suitable offer may exist or that funding will be available to close on such a transaction.
These financial statements do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts and classification of liabilities that might be necessary in the event the Company cannot continue in existence.
9
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations.
FORWARD LOOKING STATEMENT
This quarterly filing ending March 31, 2009 contains forward-looking statements that involve substantial risks and uncertainties. You can identify these statements by forward-looking words such as may, expect, plans, intends, anticipate, believe, estimate and continue or similar words and are intended to identify forward looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934. You should read statements that contain these words carefully because they discuss our future expectations or may contain projections of our future results of operations or of our financial condition or state other forward-looking information. We believe that it is important to communicate our future expectations to our investors. However, there may be events in the future that the Company is not able to accurately predict or control. Before you invest in the Companys common stock, you should be aware that the occurrence of the events described as risk factors and elsewhere in this annual filing could have a material adverse effect on our business, operating results and financial condition.
APPLICATION OF CRITICAL ACCOUNTING PRACTICES
This Managements Discussion and Analysis of Financial Condition and Results of Operations in this Quarterly Report ending March 31, 2009 on Form 10-Q should be read in conjunction with the accompanying Financial Statements and related notes. Our discussion and analysis of our financial condition and results of operations are based upon our financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. (GAAP).
Our significant accounting policies are more fully described in Notes to the financial statements. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and the related disclosures of contingent assets and liabilities. Actual results could differ from those estimates under different assumptions or conditions.
We review our estimates and assumptions on an on-going basis. Our estimates are based on our historical experience and other assumptions that we believe to be reasonable under the circumstances. Actual results are likely to differ from those estimates under different assumptions or conditions, but we do not believe such differences will materially affect our financial position or results of operations.
OVERVIEW AND PLAN OF OPERATION
We are a dietary supplement company specializing in the development, marketing and distribution of all natural, proprietary, dietary supplements under the names Trim For Life3® Appetite Control and Trim For Life3® Energy Formula.
10
In our original business plan, we outlined a marketing strategy to compete more effectively in the dietary supplement marketplace. However, due to a lack of available financing, we are unable to implement the marketing strategy or invest in product expansion. As a result, we may look to explore and identify other viable options that may provide the potential to generate a positive cash flow to accommodate the costs of being a public company. With volatile economic conditions and unknown opportunities, we are unable to adequately determine if there are indeed, business opportunities that would lend to the Company acquiring additional capital or having the available resources to construct such a deal.
The Company has been approved by the Financial Industry Regulatory Authority (FINRA) to publicly quote common stock shares on the Over-The-Counter Bulletin Board (OTCBB). The Companys trading symbol is LIPN which became effective on January 20, 2009. As a public company with the potential for shares to trade on the open market, we believe our company may be in a better position to raise additional capital to meet our operating costs. However, we cannot claim nor guarantee that by having Company stock publicly quoted that it will provide the opportunity to raise additional capital.
Our current operating costs are minimal due to limited business activities, but we do incur an expense in ongoing legal and professional services to meet our SEC obligations as a publicly held company. The Company may continue to meet these expenses by opting to raise additional capital through sales of our common stock, loans from our board of directors, and/or other transactions to meet these obligations.
We were originally organized as a New Jersey limited liability company in February 2005 under the name Life Nutrition Products, LLC ("LNP"). On September 24, 2007, Life Nutrition Products, Inc. a Delaware Corporation was formed and merged with LNP. On August 27, 2008 the Life Nutrition Products, Inc. Registration statement on Form S-1 became effective. Our principal executive office is located at 121 Monmouth Street, Red Bank, New Jersey 07701 and our phone number is (732)758-1577. Our fiscal year ends December 31.
RESULTS OF OPERATIONS
Three months ended March 31, 2009 compared to three months ended March 31, 2008
Revenue: Revenue was $959 for the three months ended March 31, 2009 compared to $360 for the three months ended March 31, 2008, an increase of $599. This increase is a result of product sales.
Gross Profit: Gross profit was $959 for the three months ended March 31, 2009 compared to $360 for the three months ended March 31, 2008, an increase of $599. This increase in gross profit is primarily attributed to sales of product that was previously reserved.
11
Selling, General and Administrative Expenses: Selling, general and administrative expenses were approximately $15,357 for the three months ended March 31, 2009 compared to $23,246 for the three months ended March 31, 2008, a decrease of $7,889.
Other Income (Expense): Other income (expense) was $0 for the three months ended March 31, 2009 compared to ($1,128) for the three months ended March 31, 2008.
IMPACT of INFLATION
Inflation has not had a material effect on our results of operations.
LIQUIDITY and CAPITAL RESOURCES
Net cash used in operating activities was $0 for the three months ended March 31, 2009, compared to net cash used by operating activites $23,787 for the three months ended March 31, 2008. This increase in cash used relates to inventory.
The Companys net cash provided by financing activities was $0 for the three months ended March 31, 2009 compared to net cash provided by financing activities of $62,447 for the three months ended March 31, 2008. The decrease was due to the Company issuing Common Stock in 2008, net of repayments of the line of credit and officers' loans. As of March 31, 2009 there are no outstanding line(s) of credit.
As of March 31, 2009, the Company had no cash.
In the year ending December 31, 2008, the Company issued 3,750,000 of common stock shares with a par value of $0.0001 in the total amount of $250,000. The proceeds of which were deemed for working capital.
Obligations are being met on a month-to-month basis as cash becomes available. There can be no assurances that the Companys present flow of cash will be sufficient to meet current and future obligations. The Company has incurred losses since its inception, and continues to require additional capital to fund operations and meet SEC requirements of being a publicly held company. As such, the Companys ability to pay its already incurred obligations is mostly dependent on the Company achieving its revenue goals or raising additional capital in the form of equity or debt.
OFF-BALANCE SHEET FINANCINGS
None
12
GOVERNMENTAL REGULATIONS
Dietary supplements are subject to federal laws dealing with drugs and regulations imposed by the FDA. Those laws regulate, among other things, health claims, ingredient labeling and nutrition content claims characterizing the level of nutrient in the product. They also prohibit the use of any health claim for dietary supplements, unless the health claim is supported by significant scientific agreement and is pre-approved by the FDA.
The Federal Trade Commission (the FTC), which exercises jurisdiction over the marketing practices and advertising of products similar to those we offer, has in the past several years instituted enforcement actions against several dietary supplement companies for deceptive marketing and advertising practices. These enforcement actions have frequently resulted in consent orders and agreements. In certain instances, these actions have resulted in the imposition of monetary redress requirements. Importantly, the FTC requires that "competent and reliable scientific evidence" corroborate each claim of health benefit made in advertising before the advertising is first made. A failure to have that evidence on hand at the time an advertisement is first made violates federal law. While we have not been the subject to enforcement action for the advertising of our products, there can be no assurance that the FTC or other agencies will not question our advertising or other operations in the future.
We believe we are in compliance with all material government regulations which apply to our products. However, we are unable to predict the nature of any future laws, regulations, interpretations or applications, nor can we predict what effect additional governmental regulations or administrative orders, when and if promulgated, would have on our business in the future.
RESEARCH AND DEVELOPMENT
Not Applicable
Item 3. Quantitative and Qualitative Disclosures About Market Risk.
We do not hold instruments that are sensitive to changes in interest rates, foreign currency exchange rates or commodity prices. Therefore, we believe that we are not materially exposed to market risks resulting from fluctuations from such rates or prices.
MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
Market Information
Our securities may be quoted on the Over-The-Counter-Bulletin-Board (OTCBB). The Companys trading symbol, LIPN became effective on January 20, 2009 to be quoted on either the Over The Counter Bulletin Board (OTCBB), OTC-Other, or the Pink Sheets. In general there is greater liquidity for traded securities on the OTCBB, and less through quotation in the Pink Sheets.
13
Even though our common stock is quoted on the OTCBB, the OTCBB provides a limited trading market, and we can make no assurances that any market-maker will agree to provide such quotations. Failure to develop or maintain an active trading market could negatively affect the value of our shares and make it difficult for shareholders to sell their shares or recover any part of their investment in the company. Even if a market for our common stock does develop, the market price of our common stock may be highly volatile so that holders of our common stock will not be able to sell their shares at prices that allow them to recover any or all of their investment. Market and industry factors may adversely affect the market price of our common stock, regardless of our actual operating performance. Factors that could cause fluctuations in our stock price may include, among other things:
-
Introductions of new products or new pricing policies by us or by our competitors;
-
The gain or loss of significant customers or product orders;
-
Actual or anticipated variations in our quarterly results;
-
The announcement of acquisitions or strategic alliances by us or by our competitors;
-
Recruitment or departure of key personnel;
-
The level and quality of securities research analyst coverage for our common stock;
-
Changes in the estimates of our operating performance or changes in recommendations by us or any research analysts that follow our stock or any failure to meet the estimates made by research analysts; and
-
Market conditions in our industry and the economy as a whole.
Common Stock
We have authorized 50,000,000 shares of common stock, par value $.0001 per share. For the period covered in this filing, our common stock has been approved for quotation on the OTCBB. For the period ending March 31, 2009, there were 43 common stock shareholders.
Preferred Stock
We have authorized 2,000,000 shares of blank check preferred stock, none of which are issued and outstanding.
Dividends
We have never paid a dividend on our Common Stock and we currently intend to retain earnings for use in our business to finance operations and growth. Any future determination as to the distribution of cash dividends will depend upon our earnings and financial position at that time and such other factors as the Board of Directors may deem appropriate.
Securities Authorized for Issuance under Equity Compensation Plans
14
The Company does not have any equity compensation plans or any individual compensation arrangements with respect to its common stock or preferred stock. The issuance of any of our common or preferred stock is within the discretion of our Board of Directors, which has the power to issue any or all of our authorized but unissued shares without stockholder approval.
Item 4. Controls and Procedures.
(a) Evaluation of Disclosure Controls and Procedures
The Company maintains a system of disclosure controls and procedures which are designed to ensure that information required to be disclosed by the Company in reports that it files or submits to the Securities and Exchange Commission under the Securities Exchange Act of 1934, as amended (the Exchange Act), including this quarterly report, ending March 31, 2009 is recorded, processed, summarized and reported on a timely basis. These disclosure controls and procedures include controls and procedures designed to ensure that information required to be disclosed under the Exchange Act is accumulated and communicated to the Companys management, including our chief executive officer and chief financial officer, as appropriate to allow for timely decisions regarding required disclosure.
(b) Changes in Internal Control over Financial Reporting
There were no changes to our internal control over financial reporting that occurred during the three months ended March 31, 2009 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
Reference should be made to Item 9A, Controls and Procedures, as disclosed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2008, filed with the SEC in April 2009. There have been no significant changes to our policies since we filed that report.
(c) Inherent Limitations on Effectiveness of Controls
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. All internal control systems, no matter how well designed, have inherent limitations. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation. Because of the inherent limitations of internal control, there is a risk that material misstatements may not be prevented or detected on a timely basis by internal control over financial reporting. However, these inherent limitations are known features of the financial reporting process. Therefore, it is possible to design into the process safeguards to reduce, though not eliminate, this risk.
15
PART IIOTHER INFORMATION
Item 1. Legal Proceedings
Not Applicable
Item 1A. Risk Factors
There are no material changes from the risk factors previously reported in our annual report on Form 10-K for the year 2008.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
The Company issued an aggregate of 45,000 shares of common stock in a three month period ending, March 31, 2009 with par value of $0.0001 in exchange for consulting services provided by Northeast Professional Planning Group.
This issuance was made in reliance upon exemptions from registration under Section 4(2) of the Securities Act.
Item 3. Defaults Upon Senior Securities
Not Applicable
Item 4. Submission of Matters to a Vote of Security Holders
There were no matters submitted to a vote of security holders through the solicitation of proxies or otherwise during the period covered in this filing ending March 31, 2009.
Item 5. Other Information.
Unregistered Sales of Equity Securities
As reported in item 2, Unregistered Sales of Equity Securities and use of Proceeds of the quarterly report ending, March 31, 2009 the detail of the transaction(s):
On January 30th, 2009, we issued 15,000 shares of common stock, par value $0.0001 to Northeast Professional Planning Group in exchange for consulting services.
On February 27, 2009, we issued 15,000 shares of common stock, par value $0.0001 to Northeast Professional Planning Group in exchange for consulting services.
On March 31, 2009, we issued 15,000 shares of common stock, par value $0.0001 to Northeast Professional Planning Group in exchange for consulting services.
16
Item 6. Exhibits.
Exhibit Number: Name:
32.1 Certification of Principal Executive Officer and Principal Financial Officer Sec. 302
32.2 Certification of Chief Executive Officer and Chief Financial Officer Sec. 906
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized on May 14, 2009.
LIFE NUTRITION PRODUCTS, INC.:
By: /s/ Michael M. Salerno
Name: Michael M. Salerno
Title: Chief Executive Officer
Date: May 14, 2009
By: /s/ Michael M. Salerno
Name: Michael M. Salerno
Title: Chief Executive Officer, Chairman
Principal Financial Officer
Principal Accounting Officer
Date: May 14, 2009
By: /s/ Richard G. Birn
Name: Richard G. Birn
Title: Vice President, Director
Date: May 14, 2009
17